Showing results (681-690 of 802) with videos related to

Sort By:
Pageof 81
Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomideSheng Wei, Xianghong Chen, Kathy Rocha, et al.
Leukemia|January 19, 2017
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858E A Eksioglu, X Chen, K-H Heider, et al.
Annals of Neurology|March 9, 2018
Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelinationBo Hu, Megan McCollum, Vignesh Ravi, et al.
Developmental Cell|August 8, 2018
Retrograde Degenerative Signaling Mediated by the p75 Neurotrophin Receptor Requires p150Glued Deacetylation by Axonal HDAC1Amrita Pathak, Emily M Stanley, F Edward Hickman, et al.
Cancer Immunology, Immunotherapy : CII|October 11, 2011
Tipifarnib-mediated suppression of T-bet-dependent signaling pathwaysFanqi Bai, Alejandro V Villagra, Jianxiang Zou, et al.
The Journal of Clinical Investigation|February 13, 2001
Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionP K Epling-Burnette, J H Liu, R Catlett-Falcone, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2019
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic SyndromesRami S Komrokji, Sheng Wei, Adam W Mailloux, et al.
Haematologica|February 4, 2014
A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response predictionRami S Komrokji, Adam W Mailloux, Dung-Tsa Chen, et al.
Mucosal Immunology|March 6, 2009
A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistenceM S Alam, C C Kurtz, J M Wilson, et al.
Molecular Pharmaceutics|May 15, 2019
In Silico Docking of Alkylphosphocholine Analogs to Human Serum Albumin Predicts Partitioning and PharmacokineticsRay R Zhang, Joseph J Grudzinksi, Tej I Mehta, et al.
Pageof 81